Rituximab (RTX)
MOR208C204
Phase 3 small_molecule completed
Quick answer
Rituximab (RTX) for Diffuse Large B-cell Lymphoma is a Phase 3 program (small_molecule) at Incyte with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte
- Indication
- Diffuse Large B-cell Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed